Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diego Cantarovitch"'
Autor:
Sarah Mafi, Marie Essig, Jean-Philippe Rerolle, Gisèle Lagathu, Romain Crochette, Véronique Brodard, Betoul Schvartz, Stephanie Gouarin, Nicolas Bouvier, Ilka Engelmann, Antoine Garstka, Céline Bressollette-Bodin, Diego Cantarovitch, Raphaële Germi, Benedicte Janbon, Christine Archimbaut, Anne-Elizabeth Heng, Françoise Garnier, Melissa Gomes-Mayeras, Anaïs Labrunie, Sébastien Hantz, Sophie Alain
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionCytomegalovirus (CMV) is the most frequent infectious complication following solid organ transplantation. Torque teno viruses (TTV) viremia has been proposed as a biomarker of functional immunity in the management of kidney transplant rec
Externí odkaz:
https://doaj.org/article/62daf4b9b9894fc996556cde9b0d9aba
Autor:
Frederic Toulza, Adam McLean, Michael Mengel, Diego Cantarovitch, Cinthia B. Drachenberg, Joseph R. Scalea, Benjamin Adam, Karine Renaudin, Hanneke de Kort, Naomi Simmonds, Michelle Willicombe, Kathy Dominy, Candice Roufosse
Publikováno v:
Clinical Transplantation, 34(11). WILEY
Pancreas transplant longevity is limited by immune rejection, which is diagnosed by graft biopsy using the Banff Classification. The histological criteria for antibody-mediated rejection (AMR) are poorly reproducible and inconsistently associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a11ee3a4b567fc74fedb8e80359691
https://pubmed.ncbi.nlm.nih.gov/32805760
https://pubmed.ncbi.nlm.nih.gov/32805760
Autor:
Jacques Dantal, Aurélie Meurette, Simon Ville, Marianne Coste-Burel, Claire Garandeau, Magali Giral, Maryvonne Hourmant, Berthe-Marie Imbert-Marcille, Diego Cantarovitch, Gilles Blancho
Publikováno v:
Transplant International
Transplant International, 2018, 31 (5), pp.484-494. ⟨10.1111/tri.13085⟩
Transplant International, 2018, 31 (5), pp.484-494. ⟨10.1111/tri.13085⟩
International audience; Post-transplantation lymphoproliferative disorder (PTLD) pathogenesis is related to EBV infection. Mismatch with the donor (EBV D+/R-) is the main risk factor for both early PTLD (1 year). In these at-risk patients, the role o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b617974bff60f6809dd0fd6e1d7b4fe
https://doi.org/10.1111/tri.13085
https://doi.org/10.1111/tri.13085